Mexico has recently reported the administration of 14,297,330 doses of measles vaccines from January 1, 2025, to February 6, 2026, as part of its Universal Vaccination Program and in response to identified measles cases, according to the Ministry of Health. This effort seeks to curb outbreaks and protect the population through widespread immunization.

In 2026 alone, the country acquired 27.3 million doses of the measles vaccine, with 23,361,000 currently available for distribution nationwide. The government emphasizes a robust supply chain to ensure that there are sufficient vaccines to meet the needs of its citizens, showcasing an organized health response to health threats posed by measles.

The vaccination strategy prioritizes infants and young children, recommending the first dose of the MR vaccine for those aged 12 months, the second dose for under 18-month-olds, and a booster shot for children at six years old. Additionally, it includes a preventive "zero" dose for children between six to twelve months old in areas experiencing ongoing outbreaks, highlighting the proactive measures taken to safeguard public health.